{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:40Z","timestamp":1707524500800},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,6]]},"DOI":"10.7759\/cureus.20195","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:22:21Z","timestamp":1638789741000},"source":"Crossref","is-referenced-by-count":0,"title":["Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor"],"prefix":"10.7759","author":[{"given":"Sunil","family":"Ruparelia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishwarya","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishari","family":"Dahrab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Cruess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2016.03.009","article-title":"Optical coherence tomography angiography in pediatric choroidal neovascularization","volume":"2","author":"Veronese C","year":"2016","unstructured":"Veronese C, Maiolo C, Huang D, Jia Y, Armstrong GW, Morara M, Ciardella AP. Optical coherence tomography angiography in pediatric choroidal neovascularization. Am J Ophthalmol Case Rep. 2016, 2:37-40. 10.1016\/j.ajoc.2016.03.009","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-620X.142598","article-title":"Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor","volume":"7","author":"Mathur G","year":"2014","unstructured":"Mathur G, George AE, Sen P. Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor. Oman J Ophthalmol. 2014, 7:141-3. 10.4103\/0974-620X.142598","journal-title":"Oman J Ophthalmol"},{"key":"ref3","article-title":"Anti-vascular endothelial growth factor indications in ocular disease","volume":"59","author":"Cornel S","year":"2015","unstructured":"Cornel S, Adriana ID, Mihaela TC, Speranta S, Algerino S, Mehdi B, Jalaladin HR. Anti-vascular endothelial growth factor indications in ocular disease. Rom J Ophthalmol. 2015, 59:235-42.","journal-title":"Rom J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3129\/i10-123","article-title":"Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series","volume":"46","author":"Kohly RP","year":"2011","unstructured":"Kohly RP, Muni RH, Kertes PJ, Lam WC. Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Can J Ophthalmol. 2011, 46:46-50. 10.3129\/i10-123","journal-title":"Can J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S161504","article-title":"Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists","volume":"12","author":"Fouzdar Jain S","year":"2018","unstructured":"Fouzdar Jain S, Song HH, Al-Holou SN, Morgan LA, Suh DW. Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists. Clin Ophthalmol. 2018, 12:1003-9. 10.2147\/OPTH.S161504","journal-title":"Clin Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200507000-00009","article-title":"Photodynamic therapy for choroidal neovascularization in pediatric patients","volume":"25","author":"Giansanti F","year":"2005","unstructured":"Giansanti F, Virgili G, Varano M, Tedeschi M, Rapizzi E, Giacomelli G, Menchini U. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina. 2005, 25:590-6. 10.1097\/00006982-200507000-00009","journal-title":"Retina"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.8.1152","article-title":"Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy","volume":"126","author":"Benevento JD","year":"2008","unstructured":"Benevento JD, Jager RD, Noble AG, et al.. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008, 126:1152-6. 10.1001\/archopht.126.8.1152","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.0059","article-title":"Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery","volume":"135","author":"Eadie BD","year":"2017","unstructured":"Eadie BD, Etminan M, Carleton BC, Maberley DA, Mikelberg FS. Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery. JAMA Ophthalmol. 2017, 135:363-8. 10.1001\/jamaophthalmol.2017.0059","journal-title":"JAMA Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4353129","article-title":"Ocular adverse effects of intravitreal bevacizumab are potentiated by intermittent hypoxia in a rat model of oxygen-induced retinopathy","volume":"2017","author":"Tan JJ","year":"2017","unstructured":"Tan JJ, Cai CL, Shrier EM, McNally L, Lazzaro DR, Aranda JV, Beharry KD. Ocular adverse effects of intravitreal bevacizumab are potentiated by intermittent hypoxia in a rat model of oxygen-induced retinopathy. J Ophthalmol. 2017, 2017:4353129. 10.1155\/2017\/4353129","journal-title":"J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1732-z","article-title":"Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report","volume":"19","author":"Kunzmann S","year":"2019","unstructured":"Kunzmann S, Ngyuen T, Stahl A, Walz JM, Nentwich MM, Speer CP, Ruf K. Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report. BMC Pediatr. 2019, 19:353. 10.1186\/s12887-019-1732-z","journal-title":"BMC Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79681-response-of-pediatric-choroidal-neovascularization-to-anti-vascular-endothelial-growth-factor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:05Z","timestamp":1707507185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79681-response-of-pediatric-choroidal-neovascularization-to-anti-vascular-endothelial-growth-factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.20195","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}